CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-27 | Throne Jason Chief Legal Officer | Option exercise | +6,424 | $13.34 | $86K | 16,424 |
| 2024-06-27 | Throne Jason Chief Legal Officer | Option exercise | +47,060 | $7.01 | $330K | 63,484 |
| 2024-06-27 | Throne Jason Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −6,424 | 41,186 | ||
| 2024-06-27 | Throne Jason Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −47,060 | 1,360 | ||
| 2024-05-31 | ROSEN TERRY J Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2024-05-31 | Kelley Susan L. Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2024-05-31 | Hampton Malcolm Garret Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2024-05-31 | Stein Jeffrey Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2024-05-31 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2024-05-31 | YARNO WENDY L Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2024-05-31 | MACKEY CATHERINE J Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2024-05-29 | WHITE MICHAEL ANTHONY Chief Scientific Officer | Option exercise 10b5-1 | +28,500 | $12.86 | $367K | 28,500 |
| 2024-05-29 | WHITE MICHAEL ANTHONY Chief Scientific Officer | Sale 10b5-1 | −27,649 | $36.23 | $1.0M | 851 |
| 2024-05-29 | WHITE MICHAEL ANTHONY Chief Scientific Officer | Sale 10b5-1 | −851 | $36.78 | $31K | 0 |
| 2024-05-29 | WHITE MICHAEL ANTHONY Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −28,500 | 64,000 | ||
| 2024-05-16 | Hata Yujiro S President and CEO | Option exercise 10b5-1 | +34,433 | $4.31 | $148K | 712,320 |
| 2024-05-16 | Hata Yujiro S President and CEO | Sale 10b5-1 | −30,084 | $41.73 | $1.3M | 682,236 |
| 2024-05-16 | Hata Yujiro S President and CEO | Sale 10b5-1 | −4,349 | $42.37 | $184K | 677,887 |
| 2024-05-16 | Hata Yujiro S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −34,433 | 49,454 | ||
| 2024-05-15 | Hata Yujiro S President and CEO | Option exercise 10b5-1 | +83,856 | $4.31 | $361K | 761,743 |
Page 3 of 10 · 186 trades